McCallin, Shawna

Shawna McCallin

 

University of Zurich
Spinal Cord Injury Center, Research
Balgrist University Hospital
Forchstrasse 340, 8008 Zurich
Tel. +41 44 510 XX XX

Email: shawna.mccallin[at]balgrist.ch

Shawna McCallin completed her Bachelor’s degree in Biology and French at the University of Pittsburgh, USA, before moving to Switzerland where she pursed her Master’s degree in Medical Biology and PhD in Life Sciences at the University of Lausanne. Her research throughout this time includes various aspects of bacteriophages and phage therapy as an alternative treatment to antibiotics, studying topics from endolysins to metagenomics of phage cocktails sold in Russian and Georgian pharmacies. Several postdoc positions at CHUV, the EPFL, and the HUG in Lausanne and Geneva, as well as involvement with startups, in microbiome and phage therapy have helped shape her research to focus on the development of phage therapy in the clinic. She holds a diploma in Clinical Trial Management from the University of Geneva and has worked on numerous clinical trials for phage therapy both as an academic and as an independent consultant.

Shawna joined the Neuro-Urology Research lab at Balgrist University Hospital in 2020 as part of the FNS-funded Singergia project, CAUTIphage, which in collaboration with the ETHZ, is developing and testing natural and engineered phage for the treatment of catheter-associated urinary tract infections (CAUTI). She is part of the executive board of the International Society for Viruses of Microorganisms, serves on the editorial board of the scientific journal, PHAGE, and is an instructor for Phages for Global Health, a non-profit organization that hosts training workshops in LMIC for phage techniques. She is also part of the Lay Communication committee within the Swiss Society of Microbiology.

A list of current publications can be found here: https://orcid.org/0000-0002-4277-7753.